Prescription medication · Anti-Thyroid Agent
propylthiouracil
Also sold as PTU. PTU treats hyperthyroidism, which is when your thyroid gland makes too much thyroid hormone.
Data updated 2026-05-15
- 1,982
- FDA reportsRarely reported
- $0.29
- Generic price (NADAC)
propylthiouracil (PTU) is a prescription Anti-Thyroid Agent. PTU treats hyperthyroidism, which is when your thyroid gland makes too much thyroid hormone.
Propylthiouracil (PTU) is a medicine that treats an overactive thyroid. It helps to lower the amount of thyroid hormone your body makes.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.29/unit
Generic Available
Yes (4 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
PTU treats hyperthyroidism, which is when your thyroid gland makes too much thyroid hormone.
Common side effects
Skin rash, Hives, Nausea
Key warnings
PTU can cause severe liver problems, including liver failure, which can be fatal.
The sections below are summarized in plain English from propylthiouracil's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
PTU works by stopping your thyroid gland from making too much thyroid hormone. It does this by interfering with the process that creates these hormones. This helps to reduce the symptoms of hyperthyroidism.
Side Effects (from patient reports)
Based on 1,982 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for propylthiouracil, by number of reports
- Hyperthyroidism
Hyperthyroidism
135 reports
- Foetal Exposure During Pregnancy
Foetal Exposure During Pregnancy
113 reports
- Nausea
Nausea
87 reports
- Exposure During Pregnancy
Exposure During Pregnancy
84 reports
- Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
83 reports
- Maternal Exposure During Pregnancy
Maternal Exposure During Pregnancy
68 reports
- Hypotension
Hypotension
67 reports
- Agranulocytosis
Agranulocytosis
59 reports
- Fatigue
Fatigue
58 reports
- Pyrexia
Pyrexia
58 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for propylthiouracil each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where propylthiouracil sits
propylthiouracil has more FDA adverse-event reports than 12% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is propylthiouracil; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 1,982 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
1,982
Reports Mentioning Death
170
8.6% of reports — not proof of cause
Hospitalization Reports
907
Top Indication
Hyperthyroidism
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 3 | HYPERTHYROIDISM | 135 |
| 4 | FOETAL EXPOSURE DURING PREGNANCY | 113 |
| 5 | NAUSEA | 87 |
| 6 | EXPOSURE DURING PREGNANCY | 84 |
| 7 | ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS | 83 |
| 8 | MATERNAL EXPOSURE DURING PREGNANCY | 68 |
| 9 | HYPOTENSION | 67 |
| 10 | AGRANULOCYTOSIS | 59 |
| 11 | FATIGUE | 58 |
| 12 | PYREXIA | 58 |
| 14 | VOMITING | 56 |
| 15 | CARDIAC ARREST | 54 |
| 16 | DIARRHOEA | 49 |
| 17 | PREMATURE BABY | 49 |
| 18 | ACUTE KIDNEY INJURY | 48 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
PTU can cause severe liver problems, including liver failure, which can be fatal. You should only use PTU if you cannot take methimazole and surgery or radioactive iodine are not right for you. PTU may be the best choice if you need an antithyroid drug during or just before the first 3 months of pregnancy.
Common Questions
What should I do if I experience nausea after taking PTU?
Can PTU affect my ability to drive or operate machinery?
How long does it take for PTU to start working?
What tests will my doctor do while I'm taking PTU?
Can I stop taking PTU once my thyroid levels are normal?
What are the symptoms of liver problems I should watch out for?
Can PTU cause hair loss?
Is it safe to take other medications with PTU?
What should I do if I think I'm having an allergic reaction to PTU?
What are the common side effects of propylthiouracil?
What drug class is propylthiouracil?
What pregnancy or breastfeeding source fields are listed for propylthiouracil?
Related Medications in Anti-Thyroid Agent
Other drugs grouped near propylthiouracil - same-class peers and common alternatives.
levothyroxine
Synthroid, Levoxyl
Levothyroxine is a medicine that replaces a hormone normally made by your thyroid gland.
Compare with propylthiouracil →
liothyronine
Cytomel
Liothyronine (Cytomel) is a medicine that replaces a thyroid hormone called T3.
Compare with propylthiouracil →
methimazole
Tapazole
Methimazole (Tapazole) is a medicine that lowers the amount of thyroid hormone your body makes.
Compare with propylthiouracil →
thyroid (desiccated)
Armour Thyroid, Nature-Throid
Armour Thyroid is a natural thyroid hormone medicine.
Compare with propylthiouracil →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for propylthiouracil: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 1,982.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 8.58%.
- leuprolide Δ 0.01 pts · 1,385 reports · GnRH Agonist 8.59%death share
- lacosamide Δ 0.02 pts · 35,350 reports · Anticonvulsant 8.56%death share
- atenolol Δ 0.07 pts · 130,943 reports · Beta-1 Selective Blocker 8.51%death share
- artificial tears Δ 0.08 pts · 2,450 reports · Ocular Lubricant 8.65%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on propylthiouracil
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for propylthiouracil
The FDA label for propylthiouracil (sold under brand names such as PTU) classifies it as a prescription-only medication in the Anti-Thyroid Agent class. PTU treats hyperthyroidism, which is when your thyroid gland makes too much thyroid hormone. Official labeling lists 18 commonly reported side effects, including Skin rash, Hives, Nausea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 1,982 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS shows a generic unit cost of $0.29.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: December 26, 2023
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages